메뉴 건너뛰기




Volumn 9, Issue 1, 2017, Pages

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

Author keywords

Cell free DNA; DNA methylation; Early diagnosis; Ovarian cancer; Personalized treatment; Screening; Serum DNA

Indexed keywords

BISULFITE; CA 125 ANTIGEN; CELL FREE NUCLEIC ACID; TUMOR MARKER;

EID: 85038919999     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-017-0500-7     Document Type: Article
Times cited : (120)

References (52)
  • 2
    • 84944871061 scopus 로고    scopus 로고
    • Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
    • Bowtell DD, Bohm S, Ahmed AA, Aspuria PJ, Bast Jr RC, Beral V, et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015;15(11):668-79.
    • (2015) Nat Rev Cancer , vol.15 , Issue.11 , pp. 668-679
    • Bowtell, D.D.1    Bohm, S.2    Ahmed, A.A.3    Aspuria, P.J.4    Bast, R.C.5    Beral, V.6
  • 3
    • 0020559574 scopus 로고
    • A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer
    • Bast Jr RC, Klug TL, St JE, Jenison E, Niloff JM, Lazarus H, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983;309(15):883-7.
    • (1983) N Engl J Med , vol.309 , Issue.15 , pp. 883-887
    • Bast, R.C.1    Klug, T.L.2    St, J.E.3    Jenison, E.4    Niloff, J.M.5    Lazarus, H.6
  • 4
    • 79958036419 scopus 로고    scopus 로고
    • Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
    • Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011;305(22):2295-303.
    • (2011) JAMA , vol.305 , Issue.22 , pp. 2295-2303
    • Buys, S.S.1    Partridge, E.2    Black, A.3    Johnson, C.C.4    Lamerato, L.5    Isaacs, C.6
  • 5
    • 79953043818 scopus 로고    scopus 로고
    • Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens
    • Cramer DW, Bast Jr RC, Berg CD, Diamandis EP, Godwin AK, Hartge P, et al. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila). 2011;4(3):365-74.
    • (2011) Cancer Prev Res (Phila) , vol.4 , Issue.3 , pp. 365-374
    • Cramer, D.W.1    Bast, R.C.2    Berg, C.D.3    Diamandis, E.P.4    Godwin, A.K.5    Hartge, P.6
  • 6
    • 84959863810 scopus 로고    scopus 로고
    • Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
    • 10022.
    • Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2016;387(10022):945-56.
    • (2016) Lancet , vol.387 , pp. 945-956
    • Jacobs, I.J.1    Menon, U.2    Ryan, A.3    Gentry-Maharaj, A.4    Burnell, M.5    Kalsi, J.K.6
  • 7
    • 84930654984 scopus 로고    scopus 로고
    • Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
    • Menon U, Ryan A, Kalsi J, Gentry-Maharaj A, Dawnay A, Habib M, et al. Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. J Clin Oncol. 2015;33(18):2062-71.
    • (2015) J Clin Oncol , vol.33 , Issue.18 , pp. 2062-2071
    • Menon, U.1    Ryan, A.2    Kalsi, J.3    Gentry-Maharaj, A.4    Dawnay, A.5    Habib, M.6
  • 8
    • 84925282761 scopus 로고    scopus 로고
    • Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer
    • Vallius T, Hynninen J, Auranen A, Carpen O, Matomaki J, Oksa S, et al. Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer. Tumour Biol. 2014;35(12):12389-95.
    • (2014) Tumour Biol , vol.35 , Issue.12 , pp. 12389-12395
    • Vallius, T.1    Hynninen, J.2    Auranen, A.3    Carpen, O.4    Matomaki, J.5    Oksa, S.6
  • 9
    • 34248329991 scopus 로고    scopus 로고
    • The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking
    • Le T, Hopkins L, Faught W, Fung-Kee-Fung M. The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking. Gynecol Oncol. 2007;105(3):712-5.
    • (2007) Gynecol Oncol , vol.105 , Issue.3 , pp. 712-715
    • Le, T.1    Hopkins, L.2    Faught, W.3    Fung-Kee-Fung, M.4
  • 10
    • 84984563841 scopus 로고    scopus 로고
    • Dynamic analysis of CA125 decline during neoadjuvant chemotherapy in patients with epithelial ovarian cancer as a predictor for platinum sensitivity
    • Pelissier A, Bonneau C, Chereau E, DE LA Motte RT, Fourchotte V, Darai E, et al. Dynamic analysis of CA125 decline during neoadjuvant chemotherapy in patients with epithelial ovarian cancer as a predictor for platinum sensitivity. Anticancer Res. 2016;36(4):1865-71.
    • (2016) Anticancer Res , vol.36 , Issue.4 , pp. 1865-1871
    • Pelissier, A.1    Bonneau, C.2    Chereau, E.3    Motte, R.T.4    Fourchotte, V.5    Darai, E.6
  • 11
    • 84920733816 scopus 로고    scopus 로고
    • CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy
    • Pelissier A, Bonneau C, Chereau E, DE LA Motte RT, Fourchotte V, Darai E, et al. CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol. 2014;135(3):542-6.
    • (2014) Gynecol Oncol , vol.135 , Issue.3 , pp. 542-546
    • Pelissier, A.1    Bonneau, C.2    Chereau, E.3    Motte, R.T.4    Fourchotte, V.5    Darai, E.6
  • 12
    • 84875520648 scopus 로고    scopus 로고
    • Analysis of circulating tumor DNA to monitor metastatic breast cancer
    • Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013;368(13):1199-209.
    • (2013) N Engl J Med , vol.368 , Issue.13 , pp. 1199-1209
    • Dawson, S.J.1    Tsui, D.W.2    Murtaza, M.3    Biggs, H.4    Rueda, O.M.5    Chin, S.F.6
  • 13
    • 84877579861 scopus 로고    scopus 로고
    • Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
    • Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 2013;497(7447):108-12.
    • (2013) Nature , vol.497 , Issue.7447 , pp. 108-112
    • Murtaza, M.1    Dawson, S.J.2    Tsui, D.W.3    Gale, D.4    Forshew, T.5    Piskorz, A.M.6
  • 14
    • 84937611698 scopus 로고    scopus 로고
    • Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
    • Wang Y, Springer S, Mulvey CL, Silliman N, Schaefer J, Sausen M, et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Sci Transl Med. 2015;7(293):293ra104.
    • (2015) Sci Transl Med , vol.7 , Issue.293
    • Wang, Y.1    Springer, S.2    Mulvey, C.L.3    Silliman, N.4    Schaefer, J.5    Sausen, M.6
  • 15
    • 84937205362 scopus 로고    scopus 로고
    • Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
    • Siravegna G, Mussolin B, Buscarino M, Corti G, Cassingena A, Crisafulli G, et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med. 2015;21(7):827.
    • (2015) Nat Med , vol.21 , Issue.7 , pp. 827
    • Siravegna, G.1    Mussolin, B.2    Buscarino, M.3    Corti, G.4    Cassingena, A.5    Crisafulli, G.6
  • 16
    • 84896371874 scopus 로고    scopus 로고
    • Detection of circulating tumor DNA in early- and late-stage human malignancies
    • Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra224.
    • (2014) Sci Transl Med , vol.6 , Issue.224 , pp. 224ra224
    • Bettegowda, C.1    Sausen, M.2    Leary, R.J.3    Kinde, I.4    Wang, Y.5    Agrawal, N.6
  • 17
    • 84949009842 scopus 로고    scopus 로고
    • Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA
    • Lanman RB, Mortimer SA, Zill OA, Sebisanovic D, Lopez R, Blau S, et al. Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA. PLoS One. 2015;10(10):e0140712.
    • (2015) PLoS One , vol.10 , Issue.10
    • Lanman, R.B.1    Mortimer, S.A.2    Zill, O.A.3    Sebisanovic, D.4    Lopez, R.5    Blau, S.6
  • 18
    • 84943375035 scopus 로고    scopus 로고
    • Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
    • Sun K, Jiang P, Chan KC, Wong J, Cheng YK, Liang RH, et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc Natl Acad Sci U S A. 2015;112(40):E5503-12.
    • (2015) Proc Natl Acad Sci U S A , vol.112 , Issue.40 , pp. E5503-E5512
    • Sun, K.1    Jiang, P.2    Chan, K.C.3    Wong, J.4    Cheng, Y.K.5    Liang, R.H.6
  • 19
    • 84971215883 scopus 로고    scopus 로고
    • Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution
    • Bartlett TE, Chindera K, McDermott J, Breeze CE, Cooke WR, Jones A, et al. Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution. Nat Commun. 2016;7:11620.
    • (2016) Nat Commun , vol.7 , pp. 11620
    • Bartlett, T.E.1    Chindera, K.2    McDermott, J.3    Breeze, C.E.4    Cooke, W.R.5    Jones, A.6
  • 20
    • 84858828509 scopus 로고    scopus 로고
    • Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation
    • Teschendorff AE, Jones A, Fiegl H, Sargent A, Zhuang JJ, Kitchener HC, et al. Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med. 2012;4(3):24.
    • (2012) Genome Med , vol.4 , Issue.3 , pp. 24
    • Teschendorff, A.E.1    Jones, A.2    Fiegl, H.3    Sargent, A.4    Zhuang, J.J.5    Kitchener, H.C.6
  • 21
    • 84861752999 scopus 로고    scopus 로고
    • Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions
    • Teschendorff AE, Widschwendter M. Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions. Bioinformatics. 2012;28(11):1487-94.
    • (2012) Bioinformatics , vol.28 , Issue.11 , pp. 1487-1494
    • Teschendorff, A.E.1    Widschwendter, M.2
  • 22
    • 84961357451 scopus 로고    scopus 로고
    • DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer
    • Teschendorff AE, Gao Y, Jones A, Ruebner M, Beckmann MW, Wachter DL, et al. DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer. Nat Commun. 2016;7:10478.
    • (2016) Nat Commun , vol.7 , pp. 10478
    • Teschendorff, A.E.1    Gao, Y.2    Jones, A.3    Ruebner, M.4    Beckmann, M.W.5    Wachter, D.L.6
  • 23
    • 80053144962 scopus 로고    scopus 로고
    • A decade of exploring the cancer epigenome - biological and translational implications
    • Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011;11(10):726-34.
    • (2011) Nat Rev Cancer , vol.11 , Issue.10 , pp. 726-734
    • Baylin, S.B.1    Jones, P.A.2
  • 25
    • 67650077151 scopus 로고    scopus 로고
    • Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer
    • deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. 2009;55(7):1337-46.
    • (2009) Clin Chem , vol.55 , Issue.7 , pp. 1337-1346
    • deVos, T.1    Tetzner, R.2    Model, F.3    Weiss, G.4    Schuster, M.5    Distler, J.6
  • 26
    • 84899550486 scopus 로고    scopus 로고
    • Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer
    • Fackler MJ, Lopez BZ, Umbricht C, Teo WW, Cho S, Zhang Z, et al. Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res. 2014;74(8):2160-70.
    • (2014) Cancer Res , vol.74 , Issue.8 , pp. 2160-2170
    • Fackler, M.J.1    Lopez, B.Z.2    Umbricht, C.3    Teo, W.W.4    Cho, S.5    Zhang, Z.6
  • 27
    • 13944250245 scopus 로고    scopus 로고
    • Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients
    • Fiegl H, Millinger S, Mueller-Holzner E, Marth C, Ensinger C, Berger A, et al. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res. 2005;65(4):1141-5.
    • (2005) Cancer Res , vol.65 , Issue.4 , pp. 1141-1145
    • Fiegl, H.1    Millinger, S.2    Mueller-Holzner, E.3    Marth, C.4    Ensinger, C.5    Berger, A.6
  • 29
    • 18544406053 scopus 로고    scopus 로고
    • DNA methylation in serum of breast cancer patients: an independent prognostic marker
    • Muller HM, Widschwendter A, Fiegl H, Ivarsson L, Goebel G, Perkmann E, et al. DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res. 2003;63(22):7641-5.
    • (2003) Cancer Res , vol.63 , Issue.22 , pp. 7641-7645
    • Muller, H.M.1    Widschwendter, A.2    Fiegl, H.3    Ivarsson, L.4    Goebel, G.5    Perkmann, E.6
  • 31
    • 84906828290 scopus 로고    scopus 로고
    • Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma
    • Potter NT, Hurban P, White MN, Whitlock KD, Lofton-Day CE, Tetzner R, et al. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem. 2014;60(9):1183-91.
    • (2014) Clin Chem , vol.60 , Issue.9 , pp. 1183-1191
    • Potter, N.T.1    Hurban, P.2    White, M.N.3    Whitlock, K.D.4    Lofton-Day, C.E.5    Tetzner, R.6
  • 32
    • 77951039961 scopus 로고    scopus 로고
    • DNA methylation based biomarkers in non-invasive cancer screening
    • Shivapurkar N, Gazdar AF. DNA methylation based biomarkers in non-invasive cancer screening. Curr Mol Med. 2010;10(2):123-32.
    • (2010) Curr Mol Med , vol.10 , Issue.2 , pp. 123-132
    • Shivapurkar, N.1    Gazdar, A.F.2
  • 33
    • 84963971785 scopus 로고    scopus 로고
    • Methylated circulating tumor DNA in blood: power in cancer prognosis and response
    • Warton K, Mahon KL, Samimi G. Methylated circulating tumor DNA in blood: power in cancer prognosis and response. Endocr Relat Cancer. 2016;23(3):R157-71.
    • (2016) Endocr Relat Cancer , vol.23 , Issue.3 , pp. R157-R171
    • Warton, K.1    Mahon, K.L.2    Samimi, G.3
  • 34
    • 84905814375 scopus 로고    scopus 로고
    • DNA methylation markers for early detection of women's cancer: promise and challenges
    • Wittenberger T, Sleigh S, Reisel D, Zikan M, Wahl B, Alunni-Fabbroni M, et al. DNA methylation markers for early detection of women's cancer: promise and challenges. Epigenomics. 2014;6(3):311-27.
    • (2014) Epigenomics , vol.6 , Issue.3 , pp. 311-327
    • Wittenberger, T.1    Sleigh, S.2    Reisel, D.3    Zikan, M.4    Wahl, B.5    Alunni-Fabbroni, M.6
  • 36
    • 84955485152 scopus 로고    scopus 로고
    • Intra-gene DNA methylation variability is a clinically independent prognostic marker in women's cancers
    • Bartlett TE, Jones A, Goode EL, Fridley BL, Cunningham JM, Berns EM, et al. Intra-gene DNA methylation variability is a clinically independent prognostic marker in women's cancers. PLoS One. 2015;10(12):e0143178.
    • (2015) PLoS One , vol.10 , Issue.12
    • Bartlett, T.E.1    Jones, A.2    Goode, E.L.3    Fridley, B.L.4    Cunningham, J.M.5    Berns, E.M.6
  • 37
    • 84945132239 scopus 로고    scopus 로고
    • HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
    • Teschendorff AE, Lee SH, Jones A, Fiegl H, Kalwa M, Wagner W, et al. HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer. Genome Med. 2015;7(1):108.
    • (2015) Genome Med , vol.7 , Issue.1 , pp. 108
    • Teschendorff, A.E.1    Lee, S.H.2    Jones, A.3    Fiegl, H.4    Kalwa, M.5    Wagner, W.6
  • 38
    • 84994715829 scopus 로고    scopus 로고
    • Correlation of smoking-associated DNA methylation changes in buccal cells with DNA methylation changes in epithelial cancer
    • Teschendorff AE, Yang Z, Wong A, Pipinikas CP, Jiao Y, Jones A, et al. Correlation of smoking-associated DNA methylation changes in buccal cells with DNA methylation changes in epithelial cancer. JAMA Oncol. 2015;1(4):476-85.
    • (2015) JAMA Oncol , vol.1 , Issue.4 , pp. 476-485
    • Teschendorff, A.E.1    Yang, Z.2    Wong, A.3    Pipinikas, C.P.4    Jiao, Y.5    Jones, A.6
  • 39
    • 63149087256 scopus 로고    scopus 로고
    • Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    • Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10(4):327-40.
    • (2009) Lancet Oncol , vol.10 , Issue.4 , pp. 327-340
    • Menon, U.1    Gentry-Maharaj, A.2    Hallett, R.3    Ryan, A.4    Burnell, M.5    Sharma, A.6
  • 40
    • 79952788617 scopus 로고    scopus 로고
    • Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling
    • Gu H, Smith ZD, Bock C, Boyle P, Gnirke A, Meissner A. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat Protoc. 2011;6(4):468-81.
    • (2011) Nat Protoc , vol.6 , Issue.4 , pp. 468-481
    • Gu, H.1    Smith, Z.D.2    Bock, C.3    Boyle, P.4    Gnirke, A.5    Meissner, A.6
  • 41
    • 84892168013 scopus 로고    scopus 로고
    • Improved reduced representation bisulfite sequencing for epigenomic profiling of clinical samples
    • Lee YK, Jin S, Duan S, Lim YC, Ng DP, Lin XM, et al. Improved reduced representation bisulfite sequencing for epigenomic profiling of clinical samples. Biol Proced Online. 2014;16(1):1.
    • (2014) Biol Proced Online , vol.16 , Issue.1 , pp. 1
    • Lee, Y.K.1    Jin, S.2    Duan, S.3    Lim, Y.C.4    Ng, D.P.5    Lin, X.M.6
  • 42
    • 0032580320 scopus 로고    scopus 로고
    • Two-sided confidence intervals for the single proportion: comparison of seven methods
    • Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857-72.
    • (1998) Stat Med , vol.17 , Issue.8 , pp. 857-872
    • Newcombe, R.G.1
  • 43
    • 84888810517 scopus 로고    scopus 로고
    • Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines
    • Sanchez-Vega F, Gotea V, Petrykowska HM, Margolin G, Krivak TC, DeLoia JA, et al. Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines. Epigenetics. 2013;8(12):1355-72.
    • (2013) Epigenetics , vol.8 , Issue.12 , pp. 1355-1372
    • Sanchez-Vega, F.1    Gotea, V.2    Petrykowska, H.M.3    Margolin, G.4    Krivak, T.C.5    DeLoia, J.A.6
  • 44
    • 84960803239 scopus 로고    scopus 로고
    • Robust detection of DNA hypermethylation of ZNF154 as a pan-cancer locus with in silico modeling for blood-based diagnostic development
    • Margolin G, Petrykowska HM, Jameel N, Bell DW, Young AC, Elnitski L. Robust detection of DNA hypermethylation of ZNF154 as a pan-cancer locus with in silico modeling for blood-based diagnostic development. J Mol Diagn. 2016;18(2):283-98.
    • (2016) J Mol Diagn , vol.18 , Issue.2 , pp. 283-298
    • Margolin, G.1    Petrykowska, H.M.2    Jameel, N.3    Bell, D.W.4    Young, A.C.5    Elnitski, L.6
  • 45
    • 34248569300 scopus 로고    scopus 로고
    • Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance
    • Gormally E, Caboux E, Vineis P, Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res. 2007;635(2-3):105-17.
    • (2007) Mutat Res , vol.635 , Issue.2-3 , pp. 105-117
    • Gormally, E.1    Caboux, E.2    Vineis, P.3    Hainaut, P.4
  • 46
    • 84964671215 scopus 로고    scopus 로고
    • The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics
    • Jiang P, Lo YM. The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics. Trends Genet. 2016;32(6):360-71.
    • (2016) Trends Genet , vol.32 , Issue.6 , pp. 360-371
    • Jiang, P.1    Lo, Y.M.2
  • 47
    • 84988433752 scopus 로고    scopus 로고
    • Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis
    • Hirsch M, Duffy J, Davis CJ, Nieves PM, Khan KS. Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis. BJOG. 2016;123:1761-8.
    • (2016) BJOG , vol.123 , pp. 1761-1768
    • Hirsch, M.1    Duffy, J.2    Davis, C.J.3    Nieves, P.M.4    Khan, K.S.5
  • 49
    • 84977508076 scopus 로고    scopus 로고
    • Validation of a biomarker panel and longitudinal biomarker performance for early detection of ovarian cancer
    • Simmons AR, Clarke CH, Badgwell DB, Lu Z, Sokoll LJ, Lu KH, et al. Validation of a biomarker panel and longitudinal biomarker performance for early detection of ovarian cancer. Int J Gynecol Cancer. 2016;26(6):1070-7.
    • (2016) Int J Gynecol Cancer , vol.26 , Issue.6 , pp. 1070-1077
    • Simmons, A.R.1    Clarke, C.H.2    Badgwell, D.B.3    Lu, Z.4    Sokoll, L.J.5    Lu, K.H.6
  • 50
    • 84967239521 scopus 로고    scopus 로고
    • Comparative analysis of circulating tumor DNA stability in KEDTA, Streck, and Cell Save blood collection tubes
    • Kang Q, Henry NL, Paoletti C, Jiang H, Vats P, Chinnaiyan AM, et al. Comparative analysis of circulating tumor DNA stability in KEDTA, Streck, and Cell Save blood collection tubes. Clin Biochem. 2016;49:1354-60.
    • (2016) Clin Biochem , vol.49 , pp. 1354-1360
    • Kang, Q.1    Henry, N.L.2    Paoletti, C.3    Jiang, H.4    Vats, P.5    Chinnaiyan, A.M.6
  • 51
    • 85014528183 scopus 로고    scopus 로고
    • Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA
    • Guo S, Diep D, Plongthongkum N, Fung HL, Zhang K, Zhang K. Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. Nat Genet. 2017;49(4):635-42.
    • (2017) Nat Genet , vol.49 , Issue.4 , pp. 635-642
    • Guo, S.1    Diep, D.2    Plongthongkum, N.3    Fung, H.L.4    Zhang, K.5    Zhang, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.